Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7483451rdf:typepubmed:Citationlld:pubmed
pubmed-article:7483451lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:7483451lifeskim:mentionsumls-concept:C0024305lld:lifeskim
pubmed-article:7483451lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:7483451lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:7483451lifeskim:mentionsumls-concept:C0679841lld:lifeskim
pubmed-article:7483451lifeskim:mentionsumls-concept:C0075727lld:lifeskim
pubmed-article:7483451pubmed:issue2lld:pubmed
pubmed-article:7483451pubmed:dateCreated1995-12-13lld:pubmed
pubmed-article:7483451pubmed:languageruslld:pubmed
pubmed-article:7483451pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:citationSubsetIMlld:pubmed
pubmed-article:7483451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7483451pubmed:statusMEDLINElld:pubmed
pubmed-article:7483451pubmed:issn0507-3758lld:pubmed
pubmed-article:7483451pubmed:authorpubmed-author:KiselevA VAVlld:pubmed
pubmed-article:7483451pubmed:authorpubmed-author:KadagidzeZ...lld:pubmed
pubmed-article:7483451pubmed:authorpubmed-author:MakhonovaL...lld:pubmed
pubmed-article:7483451pubmed:authorpubmed-author:GordinaG AGAlld:pubmed
pubmed-article:7483451pubmed:issnTypePrintlld:pubmed
pubmed-article:7483451pubmed:volume41lld:pubmed
pubmed-article:7483451pubmed:ownerNLMlld:pubmed
pubmed-article:7483451pubmed:authorsCompleteYlld:pubmed
pubmed-article:7483451pubmed:pagination80-1lld:pubmed
pubmed-article:7483451pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:meshHeadingpubmed-meshheading:7483451-...lld:pubmed
pubmed-article:7483451pubmed:year1995lld:pubmed
pubmed-article:7483451pubmed:articleTitle[Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission].lld:pubmed
pubmed-article:7483451pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7483451pubmed:publicationTypeComparative Studylld:pubmed